This is a 40-year-old female with a 6/18/2010 date of injury, when an agitated patient picked-up a heart monitor machine and slammed it into claimant's head and ribs. DIAGNOSIS: Lumbar disc displacement 12/11/15 Progress Report indicated the patient had denied Topamax increase and complained of diarrhea and worsened mood with Cymbalta. She started Cymbalta on 08/28/15. The patient was noticeably irritable. The patient reported >30 minutes late. She is inconsistent in her recount of medication effects. She said that she is more irritable but less depressed with Wellbutrin. She also noted that Cymbalta was worse, but later asserted that Cymbalta was better. Mental Status Exam showed depressed mood and irritable affect. She was rude and not …show more content…
The patient used and antidepressant Paxil with failure in the past. She self-discontinued all her medications 2 weeks prior to her initial visit. She started Cymbalta on her last visit and discussed about increasing Topamax with her neurologist. The patient reported worsening depression, sleep and persistent diarrhea. Although her neurologist agreed with increase in Topamax dose, she never started the increased dose. The patient is deemed to be at chronic elevated risk for self-harm/suicide and violence. These risk factors are mitigated by the lack of active SI/HI, no history of previous suicide attempts, motivation for treatment, sense of responsibility to family, social support, minor children living at home, safe housing and presence of a safety plan with follow-up care. There is no acute risk for suicide or violence at this time. She also experienced daytime sleepiness with Cymbalta, therefore she changed it to ahs dosing, and has noted an overall improvement in her sleep (which is not typical of Cymbalta). However, she wakes up in the middle of the night around 4-5 am. She then feels a burst of energy soon after she wakes up and she tries to get as much accomplished during this time as possible. The patient also showed pictures of her clean house and laundry in her phone, to prove her peers she is not lazy. She expressed desire to “give up” and stop taking all medications to “ride it out”. Mental Status Exam showed worse moods, anxious affect, dysthymia and irritability. Current medications: Cambia 50 mg, Cymbalta 20 mg, Neurontin 800 mg, Motrin 800 mg, Antivert (meclizine) 32 mg, Depo-provera 150 mg/ml, Amerge (naratriptan) 2.5 mg, Phenergan 12.5 mg, selenium 50 mcg, Treximet 85-500 mg, Tizanidine (Zanaflex) 4 mg, and Topiramate (Topamax) 100 mg. Treatment plan was to start
11/13/14 MRI of the lumbar spine showed 4mm left paracentral and foraminal disc protrusion at L4-5, which mildly impinges upon the thecal sac and the proximal left L5 nerve root. The disc protrusion also moderately narrows the left foramen and lateral recess. There was also a 2mm posterior central disc protrusion at L5-S1. A 2mm disc bulge at L2-3 was seen. There was a mild degenerative facet and ligament flava hypertrophy at L4-5 and
Sarah is a 31yo, G3 P1101, who is seen for an ultrasound evaluation and assessment for FTS and a consultation due to her clotting abnormalities. The patient does have a history of a 20 week IUFD and had a full thrombophilia work-up and ended up with several test results that were positive. She is heterozygous for factor V Leiden and heterozygous for prothrombin gene mutation, which is a combination that is a risk factor for thrombosis that is equal to being homozygous for either factor V Leiden or homozygous for prothrombin gene mutation. The patient herself has never had a thrombotic event. She also is heterozygous for MTHFR and PAI 4G/5G positive. She also has a positive anticardiolipin IgG antibody. In her 2nd pregnancy she was treated
Mr. Scott is a 34 year old male who presented to the ED via LEO. Mr. Scott reported to nursing staff he has not been taking medication for schizophrenia for the past 8 days because he believes the medication has not helping him with his hallucinations. Mr. Scott reports cocaine use yesterday to nurse staff. At the time of the assessment Mr. Scott is found pacing the floor of his room, However he is calm and cooperative. Mr. Scott reports he was released from a mental health facility in Chatham county. Mr. Scott mention previous hospitalization at Coastal Plains and Holly Hill. He reports a history of Bipolar, PTSD, and manic depression. Mr. Scott reports currently having suicidal thoughts of overdosing on unknown medication he has at his place of residence. Mr. Scott appears guarded and very anxious when talking to this clinician. He reports poor sleep (2-3 hours daily), experiencing flash backs of past traumas from growing up in his previous community, and visual hallucinations. Mr. Scott reports recently he would see dead bodies in the room and doors opening when he knows they are closed. Mr. Scott reports a history of suicidal ideation and attempts, the last being a month ago
The patient is a 46 year old male who presented to the ED with an alleged overdose on 200mg of Seroquel, 100mg of Lisinopril, 30 percocet, and 750mg of Trazodone. Patient reports auditory hallucinations and denies homicidal ideations. The patient reports depressive symptoms as: tearfulness, insomnia, hopelessness, worthlessness, and fatigue.
Client suffers from uncontrolled seizures and onsite medical scheduled with the neurology at Home Care Choice on Sunday, July 19, 2015. She continues to take the following medications: Topiramate tablets 100mg, Levothyroxine Sodium 75mc, Levetiracetam 750mg.
SNRI that approved to treat depression includes desvenlafaxine, duloxetine, and venlafaxine. Among these SNRIs, venlafaxine is mainly metabolized by CYP2D6, desvenlafaxine is mainly metabolized by conjugation and minor metabolized by CYP3A4, it is also an inhibitor of CYP2D6. Duloxetine is mainly metabolized by CYP1A2 and CYP2D6. Based on the information above and patient's genotyping result, desvenlafaxine will be the best choice for her. Although it is a dose-dependent inhibitor of CYP2D6, this patient has no CYP2D6 enzyme activity, desvenlafaxine won't cause the clinical impact on CYP2D6 in this
A Battle Against Himself CONNECTICUT - Ken Steele has heard voices most of his life. He was 14 years old when he started having auditory hallucinations. These voices commanded him to hurt himself and they were predicting his death. "Hang yourself," the voices told him. "The world will be better off. You 're no good, no good at all." The voices got louder and louder everyday and he was no longer in control of his life. They were. Ken’s behavior unexpectedly changed and Ken’s parents grew worried. No one was aware of what has happening. They took him to the family doctor, who announced that Ken had schizophrenia. Ken Steele at the age of 14 Subsequently,
Including fibromyalgia, a systemic review compared between 4 randomized clinical trials testing the efficacy of duloxetine in fibromyalgia. It concluded that duloxetine effectively alleviated the pain, improved the sleep and promoted the quality of life in fibromyalgia patients. Hence, FDA approved CYMBALTA, in June 2008, for the treatment of fibromyalgia. [5]
HPI: Pt reported feeling more anxious and depressed due to moving to a new location in Colorado. Pt reported sleeping adequately and feels he has good sleep on most nights. Pt does not exercise but goes on walks around his neighborhood once in a while. Pt reported he has been feeling down in the past but has not seen a PCP for this problem prior to last visit. Pt was started on citalopram 20 mg one-half tablet by PCP on 12/16/2015.
It was found that subjects on duloxetine showed significant improvements in I-QOL scores and significant decrease in IEF compared with the placebo subjects. It was also noted that 87% of patients on the placebo completed the study compared to the 69% of subjects on duloxetine. This difference can be attributed to a higher rate of duloxetine discontinuation due to side effects. Nausea was the most common side effect reported in 91% of participants, however, 81% reported resolution within 1 month. Serious adverse effects were rare and not significantly more common in the duloxetine
During the subsequent period he was under outpatient psychiatric care delivered through approximately 4 psychiatric controls per year. Psychopharmacologic treatment included antidepressants (with conversions of several different selective serotonin reuptake-inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitor (SNRI)) prescribed regularly and anxiolytics and hypnotics prescribed as needed. In 2011 quetiapine was prescribed with intention to decrease anxiolytics utilization and expected therapeutic effect on hyperarousal symptoms. Premature ejaculation and urinary urgency persisted. Urological evaluation didn't find organic basis of the difficulties.
Dr. Mccall, Thank you for your response to the assignment discussion and information. Cymbalta is a Serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant. Moreover, this is another medicine approved by the FDA for the treatment of fibromyalgia symptoms in Adults. Additionally, this medication can help with depression, anxiety, and diabetic neuropathy. Current literature reveals positive and negative information about this drug. According to the (Brown University Pharmacology Update, 2014) Cymbalta can be taken with or without food and has numerous adverse warnings listed. Some of the contrary indications to this medication is a clinical suicide risk, orthostatic hypotension, hyponatremia and liver toxicity. More importantly,
The medication that Mrs. A is on is Clozapine. The decision to use clozapine is not taken lightly because of the potentially life threatening side effect. An awareness of side effects is important to primary care practitioners because they have most contact with the patients.
Throughout psychology today there are six different theoretical models that seek to explain and treat abnormal functioning or behavior. These different models have been a result of different ideas and beliefs over the course of history. As psychology began to grow so did the improvements in research techniques. As a result psychologists are able to explain a variety of disorders in terms of the six different theoretical models. In the movie A Beautiful Mind it follows the mathematician John Nash as he struggles with schizophrenia. It an attempt to explain John Nash’s disorder the six different theoretical models will be looked at, they include biological model, psychodynamic model, behavioral model, cognitive model, humanistic model,
The patient M. is a 26 year old married female who was brought to the ER by her husband after increased anxiety and depression worsened after a “spiritual attack” that lasted for over four days. While in the ER the patient admitted to hearing multiple distant male and female voices all around her head and outside of her head. She states not being able to make out the message but interprets them to be negative in nature. She told the ER Doc she felt people were trying to harm her and that “people in her life have used things against her.” She felt her extended family may have used witchcraft and “chakra dolls” to cast spells on her. She is cognizant of the strangeness of her claims but believes them to be real